This project will explore innovative approaches to allergy treatment — including optimised allergen-specific immunotherapy, novel adjuvants, and potentially the use of engineered immune cells (e.g. regulatory T cells, CAR-T-like concepts for allergy). The aim is to analyse what limits the long-term success of current treatments and to propose biological or formulation-based solutions that could change the standard of care.

Allergies affect a growing portion of the population and remain under-addressed. Any insights into more effective, long-lasting therapies could support pipeline innovation and create commercial differentiation in a high-need space.

I’ve always found immunology inspiring — and allergy is a perfect intersection of immune complexity and clinical relevance. I want to be part of making therapies that don’t just treat symptoms but change lives.

I bring a personal passion for immunology, a track record of excellent academic performance, and a deep curiosity for how we can engineer long-term immune tolerance. I’m both ambitious and dependable, someone who contributes with insight, energy, and drive.